cdmo.directory
← Compare landing

Genevoyager (Wuhan) Co., Ltd. vs Viralgen

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/genevoyager-2/viralgen

CategoryGenevoyager (Wuhan) Co., Ltd.Viralgen
Listed sitebothcdmo
SummaryLeading CRO/CDMO provider specializing in viral vectors, proteins, and vaccines with proprietary AAV manufacturing technology and cGMP-grade facilities operational since October 2023.Viralgen is a CDMO specializing exclusively in cGMP AAV gene therapy manufacturing, with the world's largest dedicated AAV production capacity and a 100% success rate for IND/IMPD dossiers across 50+ gene therapy customers.
Services
  • Translational Research
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • Analytical Method Development & Validation
  • Regulatory Affairs
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
Modalities
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • AAV / Viral Vector Platform
  • Gene Therapy
IndicationsData not yet provided.
  • Rare Disease
Locations
  • Headquarters & cGMP Facility, Wuhan, Jiangxia District, China
  • Headquarters & Manufacturing, San Sebastián, Basque Country, Spain
Certifications
  • China · Identifier: High-tech Enterprise (高新技术企业)
  • EMA · Identifier: AEMPS/EMA certified
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.